Strategy Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$2.30B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MSTR stock price vs LDOS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LDOS's multiple
Needs Revenue / share, LDOS P/S.
Implied fair value · at MSTR's multiple
Needs MSTR P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
STRATEGY INC · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Leidos Holdings, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
MSTR vs MSFT
ORACLE CORP
MSTR vs ORCL
INTERNATIONAL BUSINESS MACHINES CORP
MSTR vs IBM
Salesforce, Inc.
MSTR vs CRM
Accenture plc
MSTR vs ACN
LOCKHEED MARTIN CORP
MSTR vs LMT
NORTHROP GRUMMAN CORP /DE/
MSTR vs NOC
GENERAL DYNAMICS CORP
MSTR vs GD
ZEBRA TECHNOLOGIES CORP
MSTR vs ZBRA
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MSTR can sustain a major rerating despite deeply negative margins and weak quality scores, then hold or buy only with a very high-risk tolerance; otherwise, the data support avoiding MSTR relative to LDOS because LDOS is far cheaper on sales and far stronger on profitability.
The valuation gap is extreme: MSTR trades at 58.6x P/S versus LDOS at 0.8x P/S, which is consistent with the model’s implied price of $1.37 and a -98.6% downside from the current price of $100.77. The historical band of $90.69-$110.85 shows MSTR is near the upper end of its own recent range even though it looks vastly expensive versus LDOS.
Supporting Metrics